Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mateusz, Kaczmarczyk"'
Publikováno v:
Psychiatria Polska. 55:555-564
Cel pracy:Celem pracy była ocena bezpieczeństwa i skuteczności przezskórnej stymulacji nerwu błędnego (taVNS) jako metody dodanej do standardowej farmakoterapii w grupie pacjentów z depresją lekooporną.Materiał i metodyPrezentujemy wyniki b
Publikováno v:
Materials and Manufacturing Processes. 36:235-244
In this paper the dependencies between face milling strategy of EN AW6082-T6 aluminum alloy samples, with difference thicknesses (6, 8, and 12 mm) and two cold rolling directions, and flatness devi...
Autor:
Jarosław, Jarczewski, Agata, Furgała, Aleksandra, Winiarska, Mateusz, Kaczmarczyk, Adrian, Poniatowski
Publikováno v:
Folia medica Cracoviensia. 59(4)
Stress is an ubiquitous phenomenon in the modern world and one of the major risk factors for cardiovascular disease. e aim of our study was to evaluate the effect of various acute stress stimuli on autonomic nervous system (ANS) activity, assessed on
Autor:
Grzegorz Porebski, Mateusz Kaczmarczyk
Publikováno v:
Alergologia Polska - Polish Journal of Allergology. 4:146-151
Drug hypersensitivity reactions (DHRs) are an important public health concern related to the safety of individuals and the costs incurred in consequence for the health care system. DHRs are functionally and clinically heterogeneous. They are classifi
Autor:
Monika Storman, Malgorzata M Bala, Dawid Storman, Alicja Domagała, Juan Nicolás Peña-Sánchez, Mateusz J Świerz, Mateusz Kaczmarczyk
Publikováno v:
European Journal of Public Health. 28
Autor:
Mateusz J Swierz, Wojciech Szot, Agnieszka Padjas, Magdalena Celińska-Löwenhoff, Anetta Undas, Mateusz Kaczmarczyk, Malgorzata M Bala
Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by the presence of antiphospholipid antibodies and subsequent arterial or venous thrombosis or pregnancy morbidity. Individuals with a definite APS diagnosis have an incre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd41c181afe32d0d29c2af19927ff5d3
https://ruj.uj.edu.pl/xmlui/handle/item/93667
https://ruj.uj.edu.pl/xmlui/handle/item/93667
Autor:
Mateusz J Swierz, Anetta Undas, Malgorzata M Bala, Magdalena Celińska-Löwenhoff, Mateusz Kaczmarczyk, Wojciech Szot, Agnieszka Padjas
Publikováno v:
Cochrane Database Syst Rev
The Cochrane Library
The Cochrane Library
BACKGROUND: Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by arterial or venous thrombosis (or both), and/or pregnancy morbidity in association with the presence of antiphospholipid antibodies. The prevalence of APS i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ede09475c1dfca89faec5c121da668a0
https://ruj.uj.edu.pl/xmlui/handle/item/94260
https://ruj.uj.edu.pl/xmlui/handle/item/94260